Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | F2rl3 | Mouse | 1,2-dichloroethane | increases expression | EXP | | 6480464 | ethylene dichloride results in increased expression of F2RL3 mRNA | CTD | PMID:28960355 | F2rl3 | Mouse | 1-naphthyl isothiocyanate | increases response to substance | EXP | | 6480464 | F2RL3 gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate | CTD | PMID:27475285 | F2rl3 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | F2rl3 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of F2RL3 mRNA | CTD | PMID:34747641 | F2rl3 | Mouse | 3',5'-cyclic AMP | multiple interactions | EXP | | 6480464 | [GYPGKF-NH(2) binds to and results in increased activity of F2RL3 protein] inhibits the reaction [Colforsin results in increased chemical synthesis of Cyclic AMP] and [GYPGKF-NH(2) binds to and results in increased activity of F2RL3 protein] which results in decreased chemical synthesis of Cyclic AMP | CTD | PMID:22207716 | F2rl3 | Mouse | 4,4'-diaminodiphenylmethane | decreases expression | EXP | | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of F2RL3 mRNA | CTD | PMID:18648102 | F2rl3 | Mouse | 6-propyl-2-thiouracil | increases expression | ISO | F2rl3 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of F2RL3 mRNA | CTD | PMID:22504374 | F2rl3 | Mouse | aristolochic acid A | increases expression | ISO | F2RL3 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of F2RL3 mRNA | CTD | PMID:33212167 | F2rl3 | Mouse | benzo[a]pyrene | affects methylation | ISO | F2RL3 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of F2RL3 promoter | CTD | PMID:27901495 | F2rl3 | Mouse | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of F2RL3 mRNA | CTD | PMID:32156529 | F2rl3 | Mouse | bivalirudin | decreases activity | ISO | F2RL3 (Homo sapiens) | 6480464 | bivalirudin results in decreased activity of F2RL3 protein | CTD | PMID:19124943 | F2rl3 | Mouse | C60 fullerene | decreases expression | ISO | F2rl3 (Rattus norvegicus) | 6480464 | fullerene C60 results in decreased expression of F2RL3 mRNA | CTD | PMID:19167457 | F2rl3 | Mouse | cadmium atom | affects methylation | ISO | F2RL3 (Homo sapiens) | 6480464 | Cadmium affects the methylation of F2RL3 gene | CTD | PMID:32484362 | F2rl3 | Mouse | calcium atom | multiple interactions | ISO | F2RL3 (Homo sapiens) | 6480464 | [alanyl-tyrosyl-prolyl-glycyl-lysyl-phenylalanine binds to and results in increased activity of F2RL3 protein] which results in increased uptake of Calcium | CTD | PMID:16702038 | F2rl3 | Mouse | calcium atom | multiple interactions | EXP | | 6480464 | F2RL3 protein affects the localization of and affects the transport of Calcium | CTD | PMID:17707436 | F2rl3 | Mouse | calcium(0) | multiple interactions | ISO | F2RL3 (Homo sapiens) | 6480464 | [alanyl-tyrosyl-prolyl-glycyl-lysyl-phenylalanine binds to and results in increased activity of F2RL3 protein] which results in increased uptake of Calcium | CTD | PMID:16702038 | F2rl3 | Mouse | calcium(0) | multiple interactions | EXP | | 6480464 | F2RL3 protein affects the localization of and affects the transport of Calcium | CTD | PMID:17707436 | F2rl3 | Mouse | chromium(6+) | multiple interactions | ISO | F2RL3 (Homo sapiens) | 6480464 | [zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of F2RL3 mRNA | CTD | PMID:38479592 | F2rl3 | Mouse | colforsin daropate hydrochloride | multiple interactions | EXP | | 6480464 | [GYPGKF-NH(2) binds to and results in increased activity of F2RL3 protein] inhibits the reaction [Colforsin results in increased chemical synthesis of Cyclic AMP] | CTD | PMID:22207716 | F2rl3 | Mouse | copper atom | increases expression | ISO | F2rl3 (Rattus norvegicus) | 6480464 | Copper deficiency results in increased expression of F2RL3 mRNA | CTD | PMID:26033743 | F2rl3 | Mouse | copper(0) | increases expression | ISO | F2rl3 (Rattus norvegicus) | 6480464 | Copper deficiency results in increased expression of F2RL3 mRNA | CTD | PMID:26033743 | F2rl3 | Mouse | cyclophosphamide | increases expression | ISO | F2rl3 (Rattus norvegicus) | 6480464 | Cyclophosphamide results in increased expression of F2RL3 protein | CTD | PMID:15643279 | F2rl3 | Mouse | Dibutyl phosphate | affects expression | ISO | F2RL3 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of F2RL3 mRNA | CTD | PMID:37042841 | F2rl3 | Mouse | diquat | decreases expression | EXP | | 6480464 | Diquat results in decreased expression of F2RL3 mRNA | CTD | PMID:36851058 | F2rl3 | Mouse | fluorene | decreases methylation | ISO | F2RL3 (Homo sapiens) | 6480464 | fluorene metabolite results in decreased methylation of F2RL3 gene | CTD | PMID:32385190 | F2rl3 | Mouse | flusilazole | decreases expression | ISO | F2rl3 (Rattus norvegicus) | 6480464 | flusilazole results in decreased expression of F2RL3 mRNA | CTD | PMID:28263823 | F2rl3 | Mouse | lidocaine | increases expression | ISO | F2rl3 (Rattus norvegicus) | 6480464 | Lidocaine results in increased expression of F2RL3 mRNA | CTD | PMID:35283115 | F2rl3 | Mouse | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of F2RL3 mRNA | CTD | PMID:12057914 | F2rl3 | Mouse | lipopolysaccharide | multiple interactions | ISO | F2RL3 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of F2RL3 mRNA | CTD | PMID:35811015 | F2rl3 | Mouse | methimazole | increases expression | ISO | F2rl3 (Rattus norvegicus) | 6480464 | Methimazole results in increased expression of F2RL3 mRNA | CTD | PMID:22504374 | F2rl3 | Mouse | oxaliplatin | multiple interactions | ISO | F2rl3 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of F2RL3 mRNA | CTD | PMID:25729387 | F2rl3 | Mouse | paracetamol | decreases expression | ISO | F2RL3 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of F2RL3 mRNA | CTD | PMID:22230336 | F2rl3 | Mouse | potassium dichromate | decreases expression | EXP | | 6480464 | Potassium Dichromate results in decreased expression of F2RL3 mRNA | CTD | PMID:23608068 | F2rl3 | Mouse | progesterone | multiple interactions | ISO | F2RL3 (Homo sapiens) | 6480464 | [GYPGKF-NH(2) binds to and results in increased activity of F2RL3 protein] inhibits the reaction [CGB3 protein results in increased chemical synthesis of Progesterone] | CTD | PMID:22207716 | F2rl3 | Mouse | resveratrol | multiple interactions | ISO | F2RL3 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of F2RL3 mRNA | CTD | PMID:23557933 | F2rl3 | Mouse | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | F2RL3 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of F2RL3 mRNA | CTD | PMID:35811015 | F2rl3 | Mouse | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide results in increased expression of F2RL3 mRNA | CTD | PMID:29341224 | F2rl3 | Mouse | Theaflavin 3,3'-digallate | affects expression | ISO | F2RL3 (Homo sapiens) | 6480464 | theaflavin-3 and 3'-digallate affects the expression of F2RL3 mRNA | CTD | PMID:34925699 | F2rl3 | Mouse | thioacetamide | increases expression | ISO | F2rl3 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of F2RL3 mRNA | CTD | PMID:34492290 | F2rl3 | Mouse | Thrombin | multiple interactions | ISO | F2RL3 (Homo sapiens) | 6480464 | Thrombin binds to and results in increased activity of [F2R protein binds to F2RL3 protein] | CTD | PMID:16505172 | F2rl3 | Mouse | topotecan | multiple interactions | ISO | F2rl3 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of F2RL3 mRNA | CTD | PMID:25729387 | F2rl3 | Mouse | triadimefon | decreases expression | ISO | F2rl3 (Rattus norvegicus) | 6480464 | triadimefon results in decreased expression of F2RL3 mRNA | CTD | PMID:28263823 | F2rl3 | Mouse | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of F2RL3 mRNA | CTD | PMID:15363585 | F2rl3 | Mouse | trimellitic anhydride | increases expression | EXP | | 6480464 | trimellitic anhydride results in increased expression of F2RL3 mRNA | CTD | PMID:19042947 | F2rl3 | Mouse | triphenyl phosphate | affects expression | ISO | F2RL3 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of F2RL3 mRNA | CTD | PMID:37042841 | F2rl3 | Mouse | Triptolide | increases expression | EXP | | 6480464 | triptolide results in increased expression of F2RL3 mRNA | CTD | PMID:32835833 | F2rl3 | Mouse | triptonide | increases expression | EXP | | 6480464 | triptonide results in increased expression of F2RL3 mRNA | CTD | PMID:33045310 | F2rl3 | Mouse | valproic acid | increases methylation | ISO | F2RL3 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of F2RL3 gene | CTD | PMID:29154799 | F2rl3 | Mouse | XL147 | multiple interactions | EXP | | 6480464 | [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of F2RL3 mRNA | CTD | PMID:27935865 | |